p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM (original) (raw)

• Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49–53 (1991).
  Article CAS Google Scholar
• Sigal, A. & Rotter, V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res. 60, 6788–6793 (2000).
  CAS PubMed Google Scholar
• Gudkov, A. Microarray analysis of p53-mediated transcription: multi-thousand piece puzzle or invitation to collective thinking. Cancer Biol. Ther. 2, 444–445 (2003).
  Article Google Scholar
• Murphy, M. E. The thousand doors that lead to death: p53-dependent repression and apoptosis. Cancer Biol. Ther. 2, 381–382 (2003).
  Article Google Scholar
• Lin, T. et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nature Cell Biol. 7, 165–171 (2005).
  Article CAS Google Scholar
• Xu, Y. A new role for p53 in maintaining genetic stability in embryonic stem cells, Cell Cycle 4, 363–364 (2005).
  Article CAS Google Scholar
• Hainaut, P. & Hollstein, M. p53 and human cancer: the first ten thousand mutations. Adv. Cancer Res. 77, 81–137 (2000).
  Article CAS Google Scholar
• Luo, J. L. et al. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene 20, 320–328 (2001).
  Article CAS Google Scholar
• Feng, L., Hollstein, M. & Xu, Y. Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle 5, 2812–2819 (2006).
  Article CAS Google Scholar
• Hergenhahn, M., Luo, J. L. & Hollstein, M. p53 designer genes for the modern mouse. Cell Cycle 3, 738–741 (2004).
  Article CAS Google Scholar
• Ben-Porath, I. & Weinberg, R. A. The signals and pathways activating cellular senescence, Int. J. Biochem. Cell Biol. 37, 961–976 (2005).
  Article CAS Google Scholar
• Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847–860 (2004).
  Article CAS Google Scholar
• Liao, M. J. et al. No requirement for V(D)J recombination in _p53_-deficient thymic lymphoma. Mol Cell Biol 18, 3495–3501 (1998).
  Article CAS Google Scholar
• Bassing, C. H. et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359–370 (2003).
  Article CAS Google Scholar
• Lista, F., Bertness, V., Guidos, C. J., Danska, J. S. & Kirsch, I. R. The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a severe combined immune deficiency (SCID) murine model. Cancer Res. 57, 4408–4413 (1997).
  CAS PubMed Google Scholar
• Kang, J., Bronson, R. T. & Xu, Y. Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair. EMBO J. 21, 1447–1455 (2002).
  Article CAS Google Scholar
• Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity. Nature Rev. Cancer 3, 155–168 (2003).
  Article CAS Google Scholar
• Xu, Y. et al. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10, 2411–2422 (1996).
  Article CAS Google Scholar
• Barlow, C. et al. _Atm_-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159–171 (1996).
  Article CAS Google Scholar
• Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499–506 (2003).
  Article CAS Google Scholar
• Xu, Y. DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis. Nature Rev. Immunol. 24, 261–270 (2006).
  Article Google Scholar
• Fernandez-Capetillo, O. et al. DNA damage-induced G2–M checkpoint activation by histone H2AX and 53BP1. Nature Cell Biol. 4, 993–997 (2002).
  Article CAS Google Scholar
• Kang, J. et al. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol. Cell Biol. 25, 661–670 (2005).
  Article CAS Google Scholar
• Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605–611 (2005).
  Article CAS Google Scholar
• You, Z., Chahwan, C., Bailis, J., Hunter, T. & Russell, P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol. Cell Biol. 25, 5363–5379 (2005).
  Article CAS Google Scholar
• Lee, J. H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11–Rad50–Nbs1 complex. Science 308, 551–554 (2005).
  Article CAS Google Scholar
• Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T. & Prives, C. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol. Cell Biol. 21, 1874–1887 (2001).
  Article CAS Google Scholar
• Lang, G. A. et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861–872 (2004).
  Article CAS Google Scholar
• Assenmacher, N. & Hopfner, K. P. MRE11/RAD50/NBS1: complex activities. Chromosoma 113, 157–166 (2004).
  Article CAS Google Scholar
• Chao, C. et al. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J. Biol. Chem. 278, 41028–41033 (2003).
  Article CAS Google Scholar